Relative Strength Chart Charles River Laboratories International, Inc. CBOE
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
CBOE
01:29:50 22/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 295.33 USD | +1.32% |
|
+3.67% | +45.99% |
| 21/08 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 20/08 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Other Biotechnology & Medical Research | +1.32% | +3.67% | - | - | - | 1.39TCr |
-
|
-
|
-
|
- Stock Market
- Stocks
- CRL Stock
- CRL Stock
- Charts Charles River Laboratories International, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
